Ovarian function in patients with systemic lupus erythematosus: Pathogenesis, drug application and prospective therapies

World J Exp Med. 2024 Jun 20;14(2):88867. doi: 10.5493/wjem.v14.i2.88867.

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which multiple organs are damaged that prevails in fertile women. Currently, glucocorticoids and immunosuppressants are widely used to treat SLE patients. However, ovarian dysfunction occurs following the use of these drugs in women with SLE. Here, we summarize recent progress in terms of understanding ovarian injury, the effects of drug application and strategies to improve ovarian function in women with SLE. This review could be helpful to precisely cure SLE in women desiring to have offspring.

Keywords: Autoimmune disease; Fertility; Mesenchymal stem cells; Ovarian insufficiency; Ovarian reserve; Systemic lupus erythematosus.

Publication types

  • Review